Team Change
Jason Kelly, co-founder and CEO of Ginkgo Bioworks, joins Compound as a Venture Partner, focusing on biotech and autonomous science.
Compound
AUG 19, 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Compound
Compound
Compound
Supp.co
The 2-Sigma Problem: The 1:1 Tutor
tech, bio, automation, AI stream of consciousness
If You're Not First, You're (Maybe? Potentially? Probably?) Last
A Quantitative Look at Biotech Platforms
Scaling Human Challenge Trials
AI Safety Has 12 Months Left
The Fickleness of Scaling Laws
The General Intelligence Company
The Decentralized Science Playbook
The Clearing Company